New cancer drug begins first human tests for Tough-to-Treat tumors
Disease control
Recruiting now
This is the first study in people to test the safety of an experimental drug called AXT-1003. It is for adults with advanced solid tumors or non-Hodgkin lymphoma that have not responded to standard treatments. The main goal is to find a safe dose and see how the body processes th…
Phase: PHASE1 • Sponsor: Axter Therapeutics (Beijing) Co., Ltd • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC